What is the definition of permissive hypercapnia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Permissive Hypercapnia Definition

Permissive hypercapnia is a ventilatory strategy that intentionally allows PaCO2 to rise above normal levels (typically accepting elevated CO2 while maintaining arterial pH ≥7.20) by using reduced tidal volumes and minute ventilation to minimize ventilator-induced lung injury from alveolar overdistension 1.

Core Concept

Permissive hypercapnia represents a deliberate acceptance of hypoventilation and CO2 retention as a trade-off for lung protection. The strategy prioritizes avoiding barotrauma and volutrauma over achieving normal blood gas values 2.

Key Parameters

pH threshold: The consensus target is maintaining pH >7.20, which has been demonstrated to be well tolerated 1. This pH threshold is the critical safety limit rather than any specific PaCO2 value.

Pressure trigger: In ARDS, peak airway pressure of 30 cmH2O is the typical trigger for employing permissive hypercapnia 1. When inspiratory pressures exceed this threshold, accepting hypercapnia becomes necessary to prevent further lung injury.

Tidal volume reduction: The strategy involves using low tidal volumes (6-8 mL/kg ideal body weight) to achieve plateau pressures ≤30 cmH2O 2.

Clinical Context

The approach emerged from recognition that conventional ventilation with normal tidal volumes (10-15 mL/kg) can cause significant parenchymal lung injury in heterogeneous lung diseases like ARDS, where small physiologic lung volumes make the lung susceptible to overdistension 3. The primary therapeutic benefit comes from reduced lung stretch, not from hypercapnia itself 4.

Important Caveats

Contraindications exist: Permissive hypercapnia causes cerebral vasodilation and increased intracranial pressure, making it potentially dangerous in brain-injured patients without ICP monitoring 5. It may also compromise myocardial contractility 1.

Context-specific application: In subarachnoid hemorrhage patients, PaCO2 levels above 37.5 mmHg may actually be beneficial, but this requires intracranial pressure monitoring for safety 5. Conversely, hypocapnia (PaCO2 <35 mmHg) should be avoided as it can cause cerebral ischemia 5.

Gradual tolerance: Gradual increases in PaCO2 are generally well-tolerated, particularly when significant acidosis does not occur 2. The strategy has shown improved survival in uncontrolled trials compared to predictive mortality models 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.